Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.46 |
| ▸ | DRD3 | P35462 | 4/20 | 0.41 |
| ▸ | CCR2 | P41597 | 1/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.38 |
| ▸ | DRD4 | P21917 | 13/20 | 0.37 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.33 |
| ▸ | DRD2 | P14416 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9935981 | 0.87 | HRH3 (0.46) | HRH3DRD3CCR2KCNH2DRD4 | |
| SCHEMBL9801701 | 0.87 | HRH3 (0.46) | HRH3DRD3CCR2KCNH2DRD4 | |
| SCHEMBL13887674 | 0.87 | HRH3 (0.46) | HRH3DRD3CCR2KCNH2DRD4 | |
| Bromide SCHEMBL19439574 | 0.85 | HRH3 (0.44) | HRH3DRD3CCR2KCNH2DRD4 | |
| SCHEMBL24859542 | 0.83 | PDK1 (0.49) | HRH3DRD3CCR2KCNH2DRD4 | |
| SCHEMBL12312340 | 0.83 | HRH3 (0.43) | HRH3DRD3CCR2KCNH2DRD4 | |
| SCHEMBL9935115 | 0.83 | DRD3 (0.47) | DRD3DRD4 | |
| SCHEMBL14968322 | 0.83 | HRH3 (0.43) | HRH3DRD3CCR2KCNH2DRD4 | |
| SCHEMBL22463771 | 0.83 | HRH3 (0.43) | HRH3DRD3CCR2KCNH2DRD4 | |
| SCHEMBL9936319 | 0.83 | HRH3 (0.43) | HRH3DRD3CCR2KCNH2DRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8546609-B2 | Ionic liquid containing allylsulfonate anion | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2013-10-01 | — | — | US | disclosed |
| EP-2474527-A1 | IONIC LIQUID CONTAINING ALLYLSULFONATE ANION | Wako Pure Chemical Industries, Ltd. (JP) | 2012-07-11 | — | — | EP | disclosed |
| US-20120157680-A1 | IONIC LIQUID CONTAINING ALLYLSULFONATE ANION | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2012-06-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120157680-A1 | IONIC LIQUID CONTAINING ALLYLSULFONATE ANION | ATXN2L, ARL1, INPPL1 | HRH3 1929/4885DRD3 812/4885CCR2 1533/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.